市場調查報告書
商品編碼
1261252
結腸鏡檢查全球市場規模、份額、行業趨勢分析報告,按應用、最終用戶、地區展望和預測,2022-2028 年Global Colonoscope Market Size, Share & Industry Trends Analysis Report By Application, By End User, By Regional Outlook and Forecast, 2022 - 2028 |
在預測期內,結腸鏡檢查市場規模預計將以 6.8% 的複合年增長率增長,到 2028 年達到 17 億美元。
此外,預計隨著結腸鏡治療能力的提高,結腸鏡手術的數量將會增加。 結腸鏡檢查市場受到越來越多的微創治療偏好、技術進步和結直腸癌流行的推動。 然而,結直腸癌的病因尚不清楚。 與其他主要地區相比,治療率的提高、結直腸癌在世界範圍內的高患病率以及高昂的藥物成本對結直腸癌的主導地位做出了重大貢獻。
此外,在結腸鏡檢查設施中,結腸鏡檢查的利用率和執行量都很高,這有助於擴大結腸鏡檢查市場。 有許多增加視角的設備,如結腸鏡、短程半徑光學系統、結腸鏡、具有多個鏡頭的胃腸設備和各種輔助設備,有助於市場增長。
COVID-19 影響分析
擇期手術在大流行期間暫停。 此外,為了限制 COVID-19 感染的風險,結腸鏡檢查中心已推遲或取消擇期和半緊急患者。 因此,這些變量表明結腸鏡檢查市場在大流行期間受到了適度的不利影響。 然而,廣泛的疫苗接種加速了結腸鏡檢查行業的發展。 近幾個月來,一些組織也齊心協力通過宣傳活動鼓勵癌症篩查,這有望推動未來的市場需求。
市場增長因素
技術進步顯著
採用高清結腸鏡檢查和成像技術升級以更好地顯示細微病變和小息肉是結腸鏡檢查最重要的技術進步之一。 HD 增加了視頻顯示中的像素數量,使向觀眾呈現更好、更詳細的圖像成為可能。 現代結腸鏡檢查系統可以產生具有 170 度視野的高清 HD 結腸鏡檢查,提供更明亮的圖像、更高的分辨率以及比標準結腸鏡檢查設備寬 30 度的視野。 考慮到這些因素,結腸鏡檢查市場預計將在整個預測期內擴大。
越來越偏愛微創手術
結腸鏡檢查是一種篩查測試,可以檢測癌症的早期症狀,並通過僅切除少量組織來防止其發展到更危險的階段。 結腸鏡檢查是一種診斷程序,其中將小型照相機插入患者的直腸以檢查大腸內壁。 該測試快速、無痛且可能挽救生命。 其直接結果是,結腸鏡檢查市場有望在預測期內擴大。
市場約束
與結腸鏡檢查相關的高風險
息肉切除術後電凝綜合徵是一種極為罕見的並發症,涉及腸道損傷。 它還可能導致胃部不適和發燒。 對於 75 歲以上的患者,結腸鏡檢查出現並發症的風險更高,因為他們更有可能患有基礎疾病。 此外,年齡較大的患者可能更難準備手術。 結果,它會導致脫水和電解質失衡。 這些並發症可能會阻止患者接受這些手術,從而阻礙結腸鏡檢查市場的增長。
應用展望
根據應用,結腸鏡檢查市場分為結直腸癌、潰瘍性結腸炎、克羅恩病等。 到 2021 年,結腸癌細分市場將在結腸鏡檢查市場中佔據最高的收入份額。 年齡、家族史、久坐不動的生活方式、飲酒、吸煙和不健康的生活方式是結直腸癌患者驚人增加的重要因素。 結腸癌是每年男性和女性中第三大最常見的癌症。 預計結直腸癌患病率的增加將導致市場擴張。
最終用戶視角
按最終用戶劃分,結腸鏡檢查市場分為醫院、門診手術中心等。 2021 年,門診手術中心部分在結腸鏡檢查市場中佔據了顯著的收入份額。 門診手術中心有望增加其市場份額,因為它們保持功能水平並且不太可能引起免疫反應。 門診手術中心擁有必要的結腸鏡檢查設備,因此可以在那裡進行手術。 此外,門診手術設施也有助於擴張,因為它們不需要過夜進行手術。
區域展望
按地區分析了北美、歐洲、亞太地區和 LAMEA 的結腸鏡檢查市場。 北美地區將在 2021 年以最大的收入份額引領結腸鏡檢查市場。 這是由於結腸癌和潰瘍性結腸炎等慢性病的高發、市場進入者的數量不斷增加以及該地區可用設備的種類越來越多。我來了。 此外,該地區研發活動的增加也有助於市場發展。
收購是市場進入者採取的主要策略。 根據發表在 Cardinal Matrix 上的一項分析,Medtronic PLC 在結腸鏡檢查市場處於領先地位。 Stryker Corporation、Fujifilm Holdings Corporation 和 Olympus Corporation 等公司是結腸鏡檢查市場的領先創新者。
The Global Colonoscope Market size is expected to reach $1.7 billion by 2028, rising at a market growth of 6.8% CAGR during the forecast period.
The colonoscopy is the primary instrument used in basic colonoscopy. In circumstances where cecal intubation is problematic due to significant colonic stricture and curvature, this instrument has a longer length and diameter than a gastroscope. It includes a control section, an instrument channel with forceps, snare, injector, and clip device, a shaft to be introduced into the patient, the tip, a connecting section, and the line.
Certain variants additionally include a lever for varying stiffness. Colonoscopy requires the use of a colonoscope. It provides superior diagnostic specificity and sensitivity compared to barium enema, stool occult blood test, and computed tomography colonography. Colonoscopy permits accurate diagnosis and treatment without the need for invasive surgery. The increasing incidence of colorectal cancer is a major factor behind expanding the colonoscope market.
Moreover, as the therapeutic capacities of colonoscopes increase, the number of colonoscopy procedures is anticipated to skyrocket. The market for colonoscope is driven by the increasing inclination for minimally invasive treatments, technological advancements, and the prevalence of colorectal cancer. However, it is uncertain what causes colorectal cancer. Increased treatment rates, a high prevalence of colon cancer globally, and elevated drug expenses relative to other major regions are significant contributors to its predominance.
The utilization and amount of colonoscopy procedures performed at these facilities contributed to expanding the colonoscope market. Many instruments that enhance visibility angles, such as colonoscopes, short-run radius optics, colonoscopes, gastrointestinal devices with multiple lenses, and various auxiliary devices, contribute to market growth.
COVID-19 Impact Analysis
During the pandemic, elective surgical procedures were temporarily halted. Furthermore, to limit the danger of COVID-19 transmission, colonoscopy centers have postponed and canceled elective and semi-urgent patients. Hence, these variables indicate that the colonoscope market experienced a moderately negative influence during the pandemic. However, due to widespread vaccination, the colonoscope industry has accelerated. In addition, several organizations have made concerted attempts to encourage cancer screening through awareness campaigns over the past few months, which is anticipated to increase future market demand.
Market Growth Factors
Rising advancements in technologies
The adoption of HD colonoscopes and upgrades in imaging techniques for excellent visibility of subtle lesions and small polyps are among the most significant technological developments in the colonoscopy. HD has increased the number of pixels on the video display, allowing for greater detail and a superior image for the spectator. Modern colonoscopy systems are able to create high-resolution, HD colonoscopes with an angle of view of 170 degrees, providing brighter images, higher resolution, and a field of vision 30 degrees broader than standard colonoscopy instruments. In light of all these factors, the colonoscope market is predicted to expand throughout the forecast period.
Growing preference for minimally invasive procedures
The colonoscopy is a screening procedure that requires only a tiny portion of tissue removal and can detect any early signs of cancer, preventing it from progressing to a more dangerous stage. Colonoscopies are diagnostic procedures that include inspecting the lining of the large intestine by inserting a tiny camera into the rectum of the patient. The process takes only a short amount of time and is completely painless, and it has the potential to save the patient's life. As a direct consequence of this, the market for colonoscope is expected to expand during the time of the projection.
Market Restraining Factors
High risks involved during the colonoscopy procedures
Post-polypectomy electrocoagulation syndrome is an extremely unusual complication involving bowel damage. It might lead to stomach discomfort and fever. Due to the increased likelihood of underlying health concerns, colonoscopies provide a larger risk of complications for patients over 75. In addition, older patients may have a more difficult time preparing for the operation. It may result in dehydration or electrolyte imbalance. These complications may discourage patients from undergoing these operations, consequently hindering the growth of the colonoscope market.
Application Outlook
Based on application, the colonoscope market is segmented into colorectal cancer, ulcerative colitis, crohns disease and others. In 2021, the colorectal cancer segment held the highest revenue share in the colonoscope market. Age, family history, a sedentary lifestyle, consumption of alcohol, smoking, and unhealthy lifestyle behaviors are important contributors to the alarming increase in colorectal cancer cases. In both men and women, colorectal cancer is the third most prevalent cancer each year. This increased incidence of colorectal cancer is anticipated to expand the market.
End User Outlook
By end user, the colonoscope market is bifurcated into hospitals, ambulatory surgery centers and others. The ambulatory surgery centers segment recorded a remarkable revenue share in the colonoscope market in 2021. While ambulatory surgery centers offer to maintain a level of function and are less likely to provoke an immunological reaction, their market share is projected to expand. The procedure is possible there because ambulatory surgery centers are equipped with the necessary colonoscopy equipment. In addition, ambulatory surgery facilities do not require an overnight stay for procedures, contributing to their expansion.
Regional Outlook
Region wise, the colonoscope market is analyzed across North America, Europe, Asia Pacific and LAMEA. The North America region led the colonoscope market by generating maximum revenue share in 2021. This is due to the high frequency of chronic diseases such as colon cancer & ulcerative colitis, the increasing number of market participants, and the rise in the variety of available devices in the region. In addition, the increase in research & development activities in the region contributes to expanding the market.
The major strategies followed by the market participants are Acquisitions. Based on the Analysis presented in the Cardinal matrix; Medtronic PLC is the forerunner in the Colonoscope Market. Companies such as Stryker Corporation, Fujifilm Holdings Corporation, Olympus Corporation are some of the key innovators in Colonoscope Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Stryker Corporation, Olympus Corporation, Fujifilm Holdings Corporation, Ambu A/S, Boston Scientific Corporation, SonoScape Medical Corp., Daichuan Medical (Shenzhen) Co., Ltd. (EndoFresh), and EndoMed Systems GmbH.
Recent Strategies Deployed in Colonoscope Market
Partnership, Collaboration and Agreement:
Jul-2022: Medtronic PLC entered into a partnership with MathWorks, an Israel-based medical technology company focused on cardiovascular disease. With this partnership, the company aimed to provide creative solutions and technologies from diagnosis to therapy.
Nov-2021: Medtronic PLC is partnering with Amazon.com to deliver pill-sized cameras to patients' doorsteps. For Medtronic, the goal is to offer a wider array of PillCams for 2021-Nov: Medtronic formed a partnership with Amazon, an American company that focuses on online advertising, e-commerce, digital streaming, cloud computing, and artificial intelligence. The partnership is aimed at delivering pillcams for patients in their homes for gastrointestinal care.
Product Launch and Product Expansion:
Nov-2021: Fujifilm revealed the ColoAssist PRO visualization system for colonoscopies. The new product allows clinicians to visualize the configuration of the endoscope throughout the procedure in real time by providing accurate navigation of the colonoscope inside the patient. The ColoAssist PRO reproduces a graphical model of the endoscope during the intubation.
Apr-2021: FUJIFILM Medical Systems U.S.A., Inc. unveiled G-EYE 700 Series Colonoscope. The new product would assist with visualization, stabilization, and control during routine examinations that would improve polyp detection when compared to standard colonoscopy. The launch of the G-EYE 700 Series line would expand the offering of the company's colonoscope portfolio.
Oct-2020: Olympus launched two colonoscopes, the PCF-H190T and the PCF-HQ190 in the market. The new PCF-H190T and the PCF-HQ190 offer extension to the existing capabilities for physicians for diagnosing and treating gastrointestinal tract disorders. Furthermore, the two new devices would improve physicians' access to and visualization of the anatomy.
Sep-2020: Olympus Corporation unveiled ENDO-AID, a platform powered by artificial intelligence (AI). The new AI platform includes the endoscopy application ENDO-AID CADe for the colon. The ENDO-AID provides a real-time display of automatically detected suspicious lesions. With this launch. the company aimed to enhance the standard of endoscopy around the world.
Acquisitions and Mergers:
Dec-2022: Olympus entered into an agreement to acquire Odin Vision, a British cloud-AI endoscopy start-up. The acquisition would enhance the company's capability to offer advanced AI-powered solutions and data-driven insights that can improve clinical and procedural workflows and potentially transform patient care.
Nov-2022: Boston Scientific Corporation signed an agreement to acquire Apollo Endosurgery, Inc, a medical technology company focused on the development of advanced therapeutic endoscopy devices. The acquisition is aimed to enter the endobariatric market and provide strong, continued growth of the company's business.
Aug-2022: Medtronic PLC completed the acquisition of Affera, Inc., a medical technology that delivers to address the cardiac arrhythmia market. Through this acquisition, the company aimed to expand its cardiac ablation portfolio that encompasses a fully integrated diagnostic, focal pulsed field, and radiofrequency ablation solution.
Nov-2020: Stryker Corporation took over Wright Medical Group N.V., a medical device company that focuses on extremities and biologics. The acquisition enables the company to enhance its market position globally in the trauma and extremities field. Additionally, the company aimed to grow the business of both companies by providing solutions that improve patient outcomes.
Aug-2020: Olympus Corporation came into an agreement to acquire Arc Medical Design Limited, a subsidiary of Norgine B.V. The acquisition showcases the company's commitment for developing advanced colonoscopy tools and its offering in gastrointestinal therapeutic devices. Moreover, with this acquisition, the company aimed to improve the early detection and treatment of colorectal cancer (CRC).
Trials and Approvals:
Nov-2021: Medtronic PLC received approval for its PillCam™ Small Bowel 3 system from U.S. Food and Drug Administration for remote endoscopy procedures. PillCam SB3 system combines Medtronic's PillCam technology with Amazon logistics which offers a convenient option for a contactless procedure and helps ensure that patients can access care in a timely manner.
May-2021: EndoFresh received approval from FDA for EndoFresh Disposable Digestive Endoscopy System. The new product features an all-in-one design with a camera system, disposable upper GI endoscope, and disposable colonoscope. The product would enable the company to allow physicians to visualize, diagnose and operate gastrointestinal endoscopy.
Apr-2021: Medtronic PLC received de novo clearance from U.S. Food and Drug Administration for its GI Genius™ intelligent endoscopy module. The GI Genius module uses artificial intelligence (AI) to identify colorectal polyps. With the addition of AI in the GI Genius intelligent endoscopy module, the launch is aimed at improving colonoscopies and polyp detection and reducing variability in patient outcomes.
Market Segments covered in the Report:
By Application
By End User
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures